Innate Pharma S.A. (IPHA) Analyst/Investor Day Transcript

Core Perspective - The event focuses on the clinical and commercial outlook for lacutamab, highlighting its significance in the market [1][2]. Medical Perspective - The presentation will include insights from medical experts Pierluigi Porcu and Sonia Quaratino, discussing the landscape and future steps for lacutamab [2]. Commercial Perspective - Stéphanie Cornen from Innate and Chris Stuessy-Vidas from ZS Associates will present on the commercial opportunities for lacutamab, including new claims data that indicate a promising market potential [3].